To investigate the incidence of cancer in arthritis patients treated with or without TNFα inhibitors (TNF-I)
To access publisher's full text version of this article click on the hyperlink belowObjectives: To i...
Objective: To determine whether TNF blockers increase tumour risk in patients with RA. Material and ...
Background: Tumour necrosis factor (TNF) antagonists have proved effective as treatment against rheu...
Background : Tumor necrosis factor (TNF) inhibitors use in patients with rheumatoid arthritis (RA) h...
Objective. To explore the influence of TNF inhibitor (TNFi) therapy and rituximab (RTX) upon the inc...
Background/aims: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid ...
Background: Existing studies of solid cancers in rheumatoid arthritis ( RA) reflect cancer morbidity...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...
Background Safety data on cancer risks following tumour necrosis factor a inhibitors (TNFi) in patie...
Objective: The objective was to compare cancer risk in a RA cohort population treated with TNF antag...
<div><h3>Background</h3><p>The risk of malignancies on TNF-α antagonists is controversial. The aim o...
Malignancies have been reported in patients with rheumatoid arthritis, psoriatic arthritis and ankyl...
Tumor necrosis factor i nhibitors (TNFi) h ave become a backbone treatment of rheumatoid arthritis (...
Background: Older studies uncovered an increased risk of cancer in patients with rheumatoid arthriti...
[[abstract]]Introduction The association between cancer and use of biologic therapy among rheumatoid...
To access publisher's full text version of this article click on the hyperlink belowObjectives: To i...
Objective: To determine whether TNF blockers increase tumour risk in patients with RA. Material and ...
Background: Tumour necrosis factor (TNF) antagonists have proved effective as treatment against rheu...
Background : Tumor necrosis factor (TNF) inhibitors use in patients with rheumatoid arthritis (RA) h...
Objective. To explore the influence of TNF inhibitor (TNFi) therapy and rituximab (RTX) upon the inc...
Background/aims: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid ...
Background: Existing studies of solid cancers in rheumatoid arthritis ( RA) reflect cancer morbidity...
Inhibitors of tumor necrosing factor alpha (TNF-a) have proven to be highly effective in the treatme...
Background Safety data on cancer risks following tumour necrosis factor a inhibitors (TNFi) in patie...
Objective: The objective was to compare cancer risk in a RA cohort population treated with TNF antag...
<div><h3>Background</h3><p>The risk of malignancies on TNF-α antagonists is controversial. The aim o...
Malignancies have been reported in patients with rheumatoid arthritis, psoriatic arthritis and ankyl...
Tumor necrosis factor i nhibitors (TNFi) h ave become a backbone treatment of rheumatoid arthritis (...
Background: Older studies uncovered an increased risk of cancer in patients with rheumatoid arthriti...
[[abstract]]Introduction The association between cancer and use of biologic therapy among rheumatoid...
To access publisher's full text version of this article click on the hyperlink belowObjectives: To i...
Objective: To determine whether TNF blockers increase tumour risk in patients with RA. Material and ...
Background: Tumour necrosis factor (TNF) antagonists have proved effective as treatment against rheu...